RxDoctor Payments Data

Sandra Hoover

Nurse Practitioner · Kansas City, MONPI 1437379534

Payments from drug & device makers

$6,713in general payments, 2019–2025

Across 350 payments — averaging $19.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Takeda Pharmaceuticals U.S.A., Inc.$755
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$710
  • Johnson & Johnson$704
  • Bristol Myers Squibb$638
  • Merck$389
  • plus $2K from 29 others

What the payments were for

  • Food & beverage$6,58798%
  • Education$1262%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,713 in reported general payments places this provider in the 95th percentile of 1,898 nurse practitioner providers in Missouri.

See all nurse practitioner providers in Missouri

Most prescribed under Part D

DrugClaimsCost to plans & patients
SucraidSacrosidase11$236,920
ZenpepLipase/Protease/Amylase27$113,157
Mesalamine22$8,579
Dexlansoprazole DrDexlansoprazole15$2,540
Pantoprazole Sodium77$1,187
Famotidine64$1,160
Colestipol Hcl11$1,022
Omeprazole90$965
Ondansetron OdtOndansetron13$350
Neomycin Sulfate11$220

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
QOL Medical, LLCSucraid$144$236,92011 claims
Aimmune Therapeutics, Inc.Zenpep$13$113,15727 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,898 nurse practitioner providers in Missouri.

Other nurse practitioner in Kansas City

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →